Specific Determination of Quinidine and Metabolites in Biological Fluids by Reversed-phase High-performance Liquid Chromatography
Overview
Affiliations
In vitro inhibition of midazolam and quinidine metabolism by flavonoids.
Ha H, Chen J, Leuenberger P, Freiburghaus A, Follath F Eur J Clin Pharmacol. 1995; 48(5):367-71.
PMID: 8641324 DOI: 10.1007/BF00194952.
Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine.
Mikus G, Ha H, Vozeh S, Zekorn C, Follath F, Eichelbaum M Eur J Clin Pharmacol. 1986; 31(1):69-72.
PMID: 3780830 DOI: 10.1007/BF00870989.
The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine.
Smalley J, Visco J, Slaughter R Br J Clin Pharmacol. 1988; 26(4):415-21.
PMID: 3190991 PMC: 1386563. DOI: 10.1111/j.1365-2125.1988.tb03400.x.
Population pharmacokinetics of quinidine.
Fattinger K, Vozeh S, Ha H, Borner M, Follath F Br J Clin Pharmacol. 1991; 31(3):279-86.
PMID: 2054269 PMC: 1368354. DOI: 10.1111/j.1365-2125.1991.tb05531.x.